Newsletter
Signup
Login
Welcome Guest
Enter Company

Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes

Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company carried out an illegal scheme to boost sales of an opioid addiction treatment.
Thu, 11 Jul 2019 14:10:26 -0400

Related News Articles

Loading...

Market blog




Advetisement



Opinion Poll

Will Real Estate Regulatory Law translate into better consumer protection on the ground?
Yes
No
Dont Know

View Results         View Comments

News Tag Cloud

Advetisement



Sign In To Crazzybull

Email ID

Password

Forgot Password?
Start in
 Join Crazzybull

STOCK WATCHLIST


    Edit stocks
Company
Account
Date
Quantity
Price
Notes
Kingfisher
BAGFilms
BHEL
ELECTROSTEEL

ADD STOCKS


    Add Stock Detail
Stock
Date
Shares
Price
Account
Notes
Select
    All / None
Kingfisher

Moneycontrol Alerts


Create alerts
Manage alerts
Stock Watch
Create new stock watch alerts  
+
Stock
How often
+

Create new stock watch alerts

Stock
How often